IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.332
AS - Asia 5.367
EU - Europa 5.330
SA - Sud America 1.269
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 21.463
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.878
SG - Singapore 2.057
RU - Federazione Russa 1.472
CN - Cina 1.348
IT - Italia 1.115
BR - Brasile 988
VN - Vietnam 860
GB - Regno Unito 854
DE - Germania 570
HK - Hong Kong 383
CA - Canada 298
UA - Ucraina 298
FR - Francia 224
FI - Finlandia 161
SE - Svezia 139
IN - India 137
DK - Danimarca 118
MX - Messico 117
AR - Argentina 107
PL - Polonia 89
BD - Bangladesh 83
TR - Turchia 76
ES - Italia 66
ID - Indonesia 64
IL - Israele 64
ZA - Sudafrica 59
IQ - Iraq 58
NL - Olanda 58
EC - Ecuador 56
IE - Irlanda 51
JP - Giappone 45
CO - Colombia 29
UZ - Uzbekistan 27
AT - Austria 25
MA - Marocco 23
PK - Pakistan 23
VE - Venezuela 23
AE - Emirati Arabi Uniti 19
PY - Paraguay 19
EG - Egitto 16
SA - Arabia Saudita 16
CL - Cile 14
LT - Lituania 14
MY - Malesia 13
JO - Giordania 12
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
CH - Svizzera 10
KE - Kenya 9
PH - Filippine 8
AU - Australia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
KZ - Kazakistan 7
BE - Belgio 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
PS - Palestinian Territory 6
BH - Bahrain 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
AZ - Azerbaigian 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
HN - Honduras 4
NP - Nepal 4
PT - Portogallo 4
RO - Romania 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BB - Barbados 3
CG - Congo 3
HU - Ungheria 3
JM - Giamaica 3
KW - Kuwait 3
LV - Lettonia 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 21.430
Salva come PNG Salva come JPEG
Città #
Dallas 1.517
Singapore 1.087
Ashburn 673
Beijing 586
San Jose 573
Southend 444
Hong Kong 349
Chicago 345
Los Angeles 342
Houston 321
Chandler 314
Moscow 287
Ho Chi Minh City 263
Fairfield 252
Ann Arbor 241
Woodbridge 225
San Mateo 200
Hanoi 160
Wilmington 158
Seattle 150
New York 143
Salt Lake City 131
Cambridge 130
The Dalles 130
Falls Church 129
Buffalo 117
São Paulo 116
Jacksonville 111
Dearborn 108
Ottawa 100
Boardman 95
Santa Clara 93
Tampa 93
Hefei 91
Lauterbourg 91
Helsinki 90
Pisa 86
Portsmouth 79
Rome 79
Stevenage 79
Warsaw 77
Munich 72
Dong Ket 68
Brooklyn 66
London 65
Milan 64
Montreal 63
Elk Grove Village 61
Orem 60
Council Bluffs 57
Lawrence 57
Mexico City 57
Beauharnois 56
Tel Aviv 55
Dublin 49
Denver 44
Frankfurt am Main 42
Istanbul 42
Johannesburg 41
Tokyo 40
Chennai 39
Stockholm 39
San Diego 37
Florence 35
Sterling 35
Rio de Janeiro 34
Atlanta 33
Lancaster 33
Phoenix 32
Poplar 32
Amsterdam 31
Toronto 31
Boston 29
Da Nang 28
Campinas 27
Tashkent 26
Turku 26
Guayaquil 24
Haiphong 24
Lappeenranta 22
Central District 21
Montréal 21
Mumbai 21
Nuremberg 21
Redwood City 21
Miami 20
Genoa 19
Belo Horizonte 18
Biên Hòa 18
Ankara 17
Baghdad 17
Dulles 17
Manchester 17
Palermo 17
San Francisco 17
Bari 16
Guangzhou 16
Detroit 15
Lucca 15
Querétaro 15
Totale 12.690
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.565
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 688
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 360
A simple echocardiographic score to rule out cardiac amyloidosis 358
A simple echocardiographic score to rule out cardiac amyloidosis 323
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 322
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 321
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 321
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 320
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 311
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 307
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 303
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 294
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 292
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 291
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 289
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 289
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 281
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 275
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 274
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 272
Sex-related differences in chronic heart failure 270
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 269
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 262
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 256
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 254
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 252
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 247
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 246
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 242
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 241
Update sui biomarcatori nello scompenso cardiaco. 240
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 240
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 236
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 233
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 232
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 228
Role of Imaging in Cardiomyopathies 226
Cardiac magnetic resonance in patients with muscular dystrophies 224
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 222
Cardiovascular disease and COVID-19: les liaisons dangereuses 220
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 219
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 218
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 218
Perspectives in noninvasive imaging for chronic coronary syndromes 213
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 209
Valvular heart disease in patients with cardiac amyloidosis 205
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 204
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 199
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 199
Molecular autopsy of sudden cardiac death in the genomics era 199
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 197
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 197
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 197
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 194
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 193
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 191
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 190
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 187
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 185
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 185
Colchicine for the treatment of coronary artery disease 182
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 180
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 180
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 177
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 176
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 174
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 173
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 168
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 167
Troponin in non-ischaemic dilated cardiomyopathy 167
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 166
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 155
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 153
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 152
Treatment of cardiac transthyretin amyloidosis: an update 150
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 149
Partial Lipodystrophy and LMNA p.R545H Variant 147
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 146
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 135
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 129
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 125
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 121
The unbearable underreporting of comorbidities in heart failure clinical trials 121
The Barthel Index in elderly acute heart failure patients. Frailty matters 120
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 116
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 114
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 109
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 107
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 99
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 79
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 65
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 54
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 45
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 38
Electrocardiographic abnormalities in patients with cardiomyopathies 34
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 30
null 29
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 28
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 27
Totale 21.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021476 0 0 0 0 0 0 0 0 0 112 171 193
2021/20221.102 122 166 37 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.130 45 54 208 67 166 214 505 970 327 915 932 727
2025/202610.431 736 1.666 1.365 1.555 1.265 769 1.052 612 762 649 0 0
Totale 21.614